AzTrials
AzTrials

Labor PainDLI-SPNCT07411352

Left Lateral Position vs Supine Position to Reduce Active Labor Duration

A study testing Left Lateral Decubitus Group and Supine Position Group in people with Labor Pain, run by Universidad Nacional Autonoma de Honduras at 1 site in Honduras.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Labor Pain
What is being tested?
Left Lateral Decubitus Group and Supine Position Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
188 participants
Where
1 siteHonduras
Study dates
15 Feb 2026to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Signed and dated informed consent form.
  • Nulliparous woman.
  • Singleton pregnancy at ≥37 weeks of gestation.
  • Intact amniotic membranes.
  • Cephalic presentation.
  • In the active phase of labor (cervical dilation ≥6 cm).
Show all 9Show fewer
  • Age ≥18 years.
  • No contraindication for vaginal delivery.
  • Possession of a mobile phone (for potential follow-up contact).

Who cannot join

  • Previous uterine surgery.
  • Maternal condition preventing vaginal delivery.
  • Fetal anomaly.
  • Premature rupture of membranes.
  • Multiple pregnancy.
  • Fetal demise.
Show all 11Show fewer
  • Uterine myomas.
  • Maternal comorbidities (e.g., chronic hypertension, diabetes mellitus type -1/2/gestational, hypothyroidism).
  • Anemia.
  • Age <18 years.
  • Preterm gestation (<37 weeks).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ricardo A. Gutierrez Ramirez, MD, MSc contact

+50497546940

ricardo.gutierrez@unah.edu.hn

Honduras1 site, 1 recruiting
  • Hospital Escuela

    Tegucigalpa, Francisco Morazán Department, 11101

    Ricardo A Gutierrez Ramirez, MD, MSc., 50497546940, ricardo.gutierrez@unah.edu.hn

    Adriana P Mendoza Batres, MD

    Recruiting

Other trials in Honduras

About this study

Official title: Left Lateral Position Versus Supine Position in Reducing the Duration of the Active Phase of Labor: A Randomized, Single-Blind Clinical Trial

This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. The intervention group will be placed in the left lateral decubitus position, while the control group will remain in the supine position. Both positions will be maintained for 30-minute intervals with 5-minute rest periods, continuing until delivery. The primary outcome is the duration of the active phase of labor. Secondary outcomes include rates of cesarean section, use of oxytocin and analgesics, and maternal and neonatal complications.

Read the detailed description

Globally, maternal positioning during labor is a key component of humanized childbirth. While the World Health Organization recommends allowing women to adopt comfortable positions, the supine position remains prevalent in many clinical settings for practitioner convenience. This study in Honduras seeks to generate local evidence on the impact of maternal position on labor progression. Nulliparous women at term (≥37 weeks) with a singleton pregnancy in cephalic presentation and in the active phase of labor (≥6 cm dilation) will be recruited from the labor and delivery unit of the Hospital Materno Infantil. After providing informed consent, participants will be randomized. The primary efficacy endpoint is the time from the onset of the active phase (or intervention start, if later) until delivery. The study hypothesizes that the left lateral position will significantly reduce active labor duration compared to the supine position, potentially reducing unnecessary surgical interventions and improving the childbirth experience.

Conditions
Labor Pain
Being tested
Left Lateral Decubitus Group, Supine Position Group
Keywords
Maternal Position, Left Lateral Position, Active Phase of Labor, Randomized Controlled Trial
Medical subject headings
Labor Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Left Lateral Decubitus GroupOther

    Participants will be placed in the left lateral decubitus position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.

  • Supine Position GroupOther

    Participants will remain in the supine position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.

Study groups in NCT07411352
Study groupRoleWhat they receive
Left Lateral Decubitus PositionExperimentalParticipants will be placed in the left lateral decubitus position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.
Receives: Other: Left Lateral Decubitus Group
Supine Position GroupActive comparatorParticipants will remain in the supine position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.
Receives: Other: Supine Position Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of the active phase of labor.

    The primary objective is to measure and compare the time taken to progress from the active phase to delivery between the two positioning groups.

    Measured: Time (in minutes) from the diagnosis of the active phase of labor (cervical dilation ≥6 cm) to delivery of the newborn. Within the first 24 hours after diagnosis of active phase.

Secondary outcomes (4)
  1. Incidence of Cesarean Delivery

    The proportion of participants in each group who undergo a cesarean section.

    Measured: From randomization until delivery (anticipated within 48 hours per participant).

  2. Use of Oxytocin for labor augmentation/conduction.

    The proportion of participants in each group who receive oxytocin infusion.

    Measured: From randomization until delivery.

  3. Incidence of maternal complications (e.g., perineal tears, hemorrhage, hypotension).

    Composite of adverse maternal outcomes recorded during labor and the immediate postpartum period.

    Measured: From randomization until hospital discharge (approximately 24-48 hours postpartum).

  4. Neonatal status as measured by Apgar score.

    The Apgar score (0-10) will be recorded and compared between groups.

    Measured: At 1 minute and 5 minutes after birth.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2026
  2. Study start15 Feb 2026 (estimated)
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a two-arm, parallel-group, randomized controlled trial (RCT) with a 1:1 allocation ratio. It employs a superiority framework to test the hypothesis that the left lateral decubitus position is superior to the standard supine position for reducing the duration of the active phase of labor. The design is single-blind, where the outcome assessors and data analysts are masked to group assignment. Due to the physical nature of the intervention (maternal positioning), participants and the healthcare providers implementing the position cannot be blinded. This is a single-center efficacy trial conducted in a real-world hospital labor and delivery setting.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
188 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07411352
Sponsor's protocol ID
PGO-UNAH-49-1-2026
Acronym
DLI-SP
Status last verified
Feb 2026
First submitted
4 Feb 2026
Last updated
13 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: The research team acknowledges the importance of data sharing but has not yet established the necessary infrastructure, resources, and legal/ethical agreements required for the secure preparation, anonymization, and controlled sharing of individual participant data (IPD). Decisions regarding future sharing will depend on internal review, compliance with Honduran data protection regulations, and securing appropriate funding and technical support for long-term data stewardship.

Publications

  • Gupta JK, Hofmeyr GJ, Shehmar M. Position in the second stage of labour for women without epidural anaesthesia. Cochrane Database Syst Rev. 2012 May 16;(5):CD002006. doi: 10.1002/14651858.CD002006.pub3.

    PubMed 22592681

Questions about this trial

What is this clinical trial studying?

A study testing Left Lateral Decubitus Group and Supine Position Group in people with Labor Pain, run by Universidad Nacional Autonoma de Honduras at 1 site in Honduras.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Honduras. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ricardo A. Gutierrez Ramirez, MD, MSc (+50497546940, ricardo.gutierrez@unah.edu.hn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of the active phase of labor. (time frame: Time (in minutes) from the diagnosis of the active phase of labor (cervical dilation ≥6 cm) to delivery of the newborn. Within the first 24 hours after diagnosis of active phase.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07411352, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in